Analystreport

Cellular Biomedicine Group Inc (NASDAQ: CBMG) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

CELLULAR BIOMEDICINE GROUP INC  (CBMG) 
Last cellular biomedicine group inc earnings: 11/6 04:25 pm Check Earnings Report
US:NASDAQ Investor Relations: cellbiomedgroup.com/investor-relations